235 related articles for article (PubMed ID: 32620533)
1. Cyto-histo correlations of plasmacytoid and micropapillary variants of high-grade urothelial carcinoma: do they fit well in The Paris System for reporting urinary cytology?
Suo L; Vega I; Thrall M
J Am Soc Cytopathol; 2021; 10(1):20-24. PubMed ID: 32620533
[TBL] [Abstract][Full Text] [Related]
2. The Paris System for Reporting Urinary Cytology reduces atypia rates and does not alter the negative predictive value of urine cytology.
McIntire PJ; Kilic I; Pambuccian SE; Wojcik EM; Barkan GA
J Am Soc Cytopathol; 2021; 10(1):14-19. PubMed ID: 33221245
[TBL] [Abstract][Full Text] [Related]
3. Split-sample comparison of urothelial cells in ThinPrep and cytospin preparations in urinary cytology: Do we need to adjust The Paris System for Reporting Urinary Cytology criteria?
Richardson CJ; Pambuccian SE; Barkan GA
Cancer Cytopathol; 2020 Feb; 128(2):119-125. PubMed ID: 31774630
[TBL] [Abstract][Full Text] [Related]
4. Urinary tract cytology: a cytologic-histopathologic correlation with The Paris System, an institutional study.
Danakas A; Sweeney M; Cheris S; Agrawal T
J Am Soc Cytopathol; 2021; 10(1):56-63. PubMed ID: 33132054
[TBL] [Abstract][Full Text] [Related]
5. High-grade urothelial carcinoma in urine cytology: different spaces - different faces, highlighting morphologic variance.
McIntire PJ; Elsoukkary SS; Robinson BD; Siddiqui MT
J Am Soc Cytopathol; 2021; 10(1):36-40. PubMed ID: 32958411
[TBL] [Abstract][Full Text] [Related]
6. The Paris System "atypical urothelial cells" category: can the current criteria be improved?
Vosoughi A; Ordobazari A; Lora Gonzalez MA; Guido LP; Skiba M; Campuzano-Zuluaga G; Kryvenko ON; Gomez-Fernandez C; Garcia-Buitrago M; Jorda M
J Am Soc Cytopathol; 2021; 10(1):3-8. PubMed ID: 32732113
[TBL] [Abstract][Full Text] [Related]
7. Urine cytomorphology of micropapillary urothelial carcinoma.
Zhu B; Rohan SM; Lin X
Diagn Cytopathol; 2013 Jun; 41(6):485-91. PubMed ID: 22623512
[TBL] [Abstract][Full Text] [Related]
8. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.
Vlajnic T; Gut A; Savic S; Bubendorf L
J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041
[TBL] [Abstract][Full Text] [Related]
9. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature.
Pastorello RG; Barkan GA; Saieg M
J Am Soc Cytopathol; 2021; 10(1):79-87. PubMed ID: 33160893
[TBL] [Abstract][Full Text] [Related]
10. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology.
Cowan ML; Rosenthal DL; VandenBussche CJ
Cancer Cytopathol; 2017 Jun; 125(6):427-434. PubMed ID: 28272842
[TBL] [Abstract][Full Text] [Related]
11. Urinary tract cytology showing variant morphology and divergent differentiation.
Arshia A; Hassan FA; Hensley PJ; Allison DB
Cytopathology; 2024 Mar; 35(2):199-212. PubMed ID: 37919868
[TBL] [Abstract][Full Text] [Related]
12. An institutional experience evaluating hTERT immunostaining in 100 consecutive ThinPrep urine specimens.
Xing J; Han M; Monaco SE; Dhir R; Roy S; Pantanowitz L
J Am Soc Cytopathol; 2021; 10(1):88-93. PubMed ID: 32354607
[TBL] [Abstract][Full Text] [Related]
13. A new 7-point method facilitates accurate diagnosis of high-grade urothelial carcinoma in routine urinary cytology practice.
Iwai S; Mimura A; Ohtani H; Shimokama T; Kinjo M
J Am Soc Cytopathol; 2021; 10(1):103-109. PubMed ID: 33092994
[TBL] [Abstract][Full Text] [Related]
14. Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma.
Straccia P; Martini M; Sacco E; Bassi PF; Pierconti F
Diagn Cytopathol; 2020 Feb; 48(2):111-117. PubMed ID: 31650714
[TBL] [Abstract][Full Text] [Related]
15. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.
Zheng X; Si Q; Du D; Harshan M; Zhang Z; Haines K; Shi W; Chhieng DC
Cytopathology; 2018 Apr; 29(2):184-188. PubMed ID: 29251368
[TBL] [Abstract][Full Text] [Related]
16. Outcome analysis and negative predictive value of the "unsatisfactory/nondiagnostic" category of The Paris System for Reporting Urinary Cytology.
Abro S; Nomani L; Wojcik EM; Pambuccian SE; Chatt G; Barkan GA
J Am Soc Cytopathol; 2021; 10(1):64-70. PubMed ID: 33279453
[TBL] [Abstract][Full Text] [Related]
17. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
[TBL] [Abstract][Full Text] [Related]
18. Two-year study on the application of the Paris system for urinary cytology in a cancer centre.
de Paula R; Oliveira A; Nunes W; Bovolim G; Domingos T; De Brot L; Bezerra S; Cunha I; Morini M; Saieg M
Cytopathology; 2020 Jan; 31(1):41-46. PubMed ID: 31654587
[TBL] [Abstract][Full Text] [Related]
19. Pleural fluid metastasis of plasmacytoid urothelial carcinoma in comparison to micropapillary and conventional high-grade urothelial carcinoma: Cytologic and immuonohistochemical findings.
Wang BG; Woodward K; Menezes G; Wang ZQ; He R; Li W
Diagn Cytopathol; 2022 Sep; 50(9):E248-E254. PubMed ID: 35560555
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based diagnostic accuracy measurement in urine cytology using likelihood ratios.
Myles N; Auger M; Kanber Y; Caglar D; Kassouf W; Brimo F
J Am Soc Cytopathol; 2021; 10(1):71-78. PubMed ID: 33071190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
